Requip and Pleurisy - a phase IV clinical study of FDA data

Summary:

Pleurisy is reported as a side effect among people who take Requip (ropinirole hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Lasix, and have High blood pressure.

The phase IV clinical study analyzes which people have Pleurisy when taking Requip. It is created by eHealthMe based on reports of 21,866 people who have side effects when taking Requip from the FDA, and is updated regularly.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

What is Pleurisy?

Pleurisy (inflammation of the pleurae, which causes pain when breathing) is found to be associated with 808 drugs and 1,141 conditions by eHealthMe. Check the latest studies of Pleurisy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 03, 2026

21,866 people reported to have side effects when taking Requip.
Among them, 15 people (0.07%) have Pleurisy.

Among these 15 people:

How long have people been on Requip when they have Pleurisy? *

What is the gender of people who have Pleurisy when taking Requip? *

female: 46.67 %
male: 53.33 %

What is the age of people who have Pleurisy when taking Requip? *

What are other drugs people take besides Requip? *

What are other side effects people have besides Pleurisy? *

Dyspnea (difficult or laboured breathing): 7 people, 46.67%
Weight Increased: 4 people, 26.67%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 26.67%
Chest Pain: 4 people, 26.67%
Back Pain: 4 people, 26.67%
Fatigue (feeling of tiredness): 4 people, 26.67%
Pleural Effusion (water on the lungs): 4 people, 26.67%
Urinary Tract Infection: 4 people, 26.67%
Panic Disorder: 3 people, 20.00%
Weakness: 3 people, 20.00%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 26.67%
Type 2 Diabetes: 3 people, 20.00%
Stress And Anxiety: 3 people, 20.00%
Sleep Disorder: 3 people, 20.00%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 3 people, 20.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 20.00%
High Blood Cholesterol: 3 people, 20.00%
Fungal Infection: 3 people, 20.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 20.00%
Feeling Of Relaxation: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Requip and have Pleurisy?

- Check whether Pleurisy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Requip:

Requip (22,950 reports)

Pleurisy treatments and more:

Pleurisy (9,090 reports)

Browse all side effects of Requip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pleurisy:

Pleurisy (808 drugs)

Browse all the conditions that are associated with Pleurisy:

Pleurisy (1,141 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ropinirole hydrochloride (the active ingredients of Requip) and Requip (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.